Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEMPEGALDESLEUKIN vs BENDAMUSTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEMPEGALDESLEUKIN vs BENDAMUSTINE: Safety Overview

Metric BEMPEGALDESLEUKIN BENDAMUSTINE
Total FAERS Reports 174 19,667
Deaths Reported 22 3,988
Death Rate 12.6% 20.3%
Hospitalizations 159 7,576
Average Patient Age 64.9 yrs 65.5 yrs
% Female Patients 23.6% 40.1%
FDA Approval Date N/A Apr 28, 2023
Manufacturer N/A Azurity Pharmaceuticals, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription